03 Apr 2020 administrator COVID19, Hočkinov limfom, Hronična limfocitna leukemija, Leukemije, Multipli mijelom, Nehočkinski limfom FINDINGS FROM A RETROSPECTIVE CASE STUDY OF COVID-19 INFECTION IN CANCER PATIENTS IN WUHAN: AN EMPHASIS ON SEVERE EVENTS Analysis of risk factors associated with admission to an intensive care unit, the use of mechanical ventilation or deathDate:30 Mar
02 Apr 2020 administrator Hronična limfocitna leukemija, Nehočkinski limfom Implementation of CAR T-cell therapy in the real world – A round table discussion The Lymphoma Hub is pleased to report a summary of real-world experiences of chimeric antigen receptor (CAR) T-cell implementation as discussed
01 Apr 2020 administrator COVID19 COVID-19: WHY WE SHOULD ALL WEAR MASKS — THERE IS NEW SCIENTIFIC RATIONALE The official recommendation in the United States (and other Western countries) that the public should not wear face masks was motivated by the
06 Aug 2019 administrator Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies Overweight and obesity are a global health problem. During the last 40 years, the number of obese adults increased from 100 million in 1975 (69
14 Jun 2019 administrator Uncategorized “Impressive” results of a new approach to relapsed or refractory Hodgkin lymphoma Phase 2 study finds that a new treatment combination may improve outcomes for people with relapsed or refractory Hodgkin lymphoma. A recent,